SimInhale Symposium at DDL2017

Our COO Wim Vos had a very interesting discussion this morning on drug delivery into the lungs of children and infants. Can FLUIDDA‘s FRI be the tool to evaluate the performance of nebulized , DPI or soft mist delivery in this population? SimInhale #DDL2017

Sorry, comments are closed for this post.